LifeVantage Corp
NASDAQ:LFVN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its 3-Year Average (8), the stock would be worth $8.9 (86% upside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 4.3 | $4.78 |
0%
|
| 3-Year Average | 8 | $8.9 |
+86%
|
| 5-Year Average | 5.5 | $6.12 |
+28%
|
| Industry Average | 9.3 | $10.32 |
+116%
|
| Country Average | 14.4 | $15.99 |
+235%
|
Forward EV/EBITDA
Today’s price vs future ebitda
| Today's Enterprise Value | EBITDA | Forward EV/EBITDA | ||
|---|---|---|---|---|
|
$48.8m
|
/ |
Jan 2026
$11.9m
|
= |
|
|
$48.8m
|
/ |
Jun 2026
$16.7m
|
= |
|
|
$48.8m
|
/ |
Jun 2027
$16.1m
|
= |
|
|
$48.8m
|
/ |
Jun 2028
$11.6m
|
= |
|
Forward EV/EBITDA shows whether today’s EV/EBITDA still looks high or low once future ebitda are taken into account.
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| US |
|
LifeVantage Corp
NASDAQ:LFVN
|
61.1m USD | 4.3 | 7.6 | |
| FR |
|
L'Oreal SA
PAR:OR
|
190.4B EUR | 17.7 | 31.1 | |
| UK |
|
Unilever PLC
LSE:ULVR
|
93.8B GBP | 11.5 | 11.4 | |
| IN |
|
Hindustan Unilever Ltd
NSE:HINDUNILVR
|
5T INR | 34.8 | 36.2 | |
| UK |
|
HALEON PLC
LSE:HLN
|
31.9B GBP | 13.4 | 19.2 | |
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
27.6B USD | 14.3 | -154.8 | |
| DE |
|
Beiersdorf AG
XETRA:BEI
|
17.2B EUR | 8.7 | 18.3 | |
| JP |
|
Kao Corp
TSE:4452
|
2.7T JPY | 10 | 22.6 | |
| IN |
|
Godrej Consumer Products Ltd
NSE:GODREJCP
|
1.1T INR | 36.5 | 60.6 | |
| CA |
|
Relevium Technologies Inc
XTSX:RLV
|
12.2B CAD | -6 373.4 | -4 624.4 | |
| IN |
|
Dabur India Ltd
NSE:DABUR
|
758.3B INR | 31 | 42.7 |
Market Distribution
| Min | 0 |
| 30th Percentile | 10 |
| Median | 14.4 |
| 70th Percentile | 21.5 |
| Max | 1 767 274.1 |
Other Multiples
LifeVantage Corp
Glance View
LifeVantage Corp. engages in the identification, research, development and distribution of advanced nutraceutical dietary supplements and personal care products. The company is headquartered in Lehi, Utah and currently employs 160 full-time employees. The company went IPO on 2012-09-12. Its products include Protandim, LifeVantage Omega+, ProBio and Daily Wellness dietary supplements, TrueScience, Axio and PhysIQ. LifeVantage Omega+ is a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and Vitamin D3 to support cognitive health, cardiovascular health, skin health, and the immune system. ProBio is a dietary supplement designed to support optimal digestion and immune system function. Daily Wellness is a dietary supplement designed to support and strengthen immune health. TrueScience, which consists of facial cleanser, perfecting lotion, eye serum. PhysIQ, which consists of fat burn, prebiotic and whey protein.
